December 3, 2019
Tar Heal Tuesday is how UNC celebrates the international day of giving, Giving Tuesday! For the past seven years, nonprofits and charities all over the globe have celebrated Giving Tuesday on the Tuesday after Thanksgiving in order to kick off the season of giving. UNC Lineberger is doing our part today to secure a healthier …
December 2, 2019
Sophie Steiner loved all things Chapel Hill, especially the music scene. She also was passionate about improving cancer care and services for adolescents and young adults. For the past five years, her family and the Be Loud! Sophie Foundation have honored her legacy as a champion for other young people with cancer. Diagnosed with a …
December 2, 2019
The North Carolina Biotechnology Center awarded $100,000 to UNC Lineberger Comprehensive Cancer Center’s Chad Pecot, MD, to study an experimental treatment that would silence a gene commonly mutated in cancer. Using a Nobel Prize-winning technology called RNA interference or RNAi, Pecot’s lab designed an investigational drug to shut down the mutated version of the KRAS …
December 1, 2019
The Web of Science Group’s 2019 Highly Cited Researchers list recognized 18 UNC Lineberger members for being among the world’s most influential researchers of the past decade. The listing is limited to researchers who have published multiple highly-cited papers that rank in the top 1 percent by citations for field and year. Approximately only 6,200 …
November 29, 2019
Midway through treatment for head and neck cancer, Jeff Cobb had a question for his doctors at UNC Lineberger. “Can I run a marathon?”
November 26, 2019
A group from the Coldwell Banker Howard Perry and Walston real estate agency presented a $42,000 donation to UNC Lineberger to support its Comprehensive Cancer Support Program at the North Carolina Cancer Hospital. HPW raised the funds during its 2019 Pig Out For The Cure event in September. Pig Out For The Cure is an …
November 26, 2019
The honor recognizes Der's contributions to cancer research. His lab's recent findings on pancreatic cancer have led to clinical studies of a new treatment.
November 21, 2019
In Clinical Cancer Research, a journal of the American Association for Cancer Research, Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings for how two subtypes of pancreatic cancer respond to treatments differently. Importantly, they found that one subtype of the disease showed poor responses to common therapies and also had worse survival outcomes.
November 18, 2019
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
November 18, 2019
The Society for Immunotherapy of Cancer honored Rahul Mirlekar, PhD, a postdoctoral research associate at UNC Lineberger, as a recipient of its 2019 Young Investigator Award. The society honored Mirlekar at its 34th Annual Meeting, held Nov. 6-10 in National Harbor, Maryland. The meeting was expected to attract more than 4,000 researchers, clinicians, pharmacists and …
